glp-1 agonist comparison chart Table 1 from Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Drug Class Review Changes in A1C values with
Description
Triple-Hormone-Receptor agonist Retatrutide for Obesity - A phase 2 trial
As is the case with azelaprag, we currently have no idea how these medications will perform in people taking weight-loss drugs, either

Early observational studies suggested lower colorectal cancer incidence among patients treated with GLP-1 agents compared with those receiving other glucose-lowering therapies
Boehncke, Genve (Dermatologie)

doi: 10.1016/j.mce.2007.06.003

These are in varying phases of preclinical or early clinical study
